Panel Community Conversations track
AASLD/INASL: Updates on Diagnosis and Treatment of Hepatic Encephalopathy
Fri, Nov 6, 2026 · 2:00–3:00 PM MST Convention Center: Bluebird Ballroom 2GH, Colorado Convention Center
About this session
Hepatic encephalopathy (HE) remains a major challenge in the management of chronic liver disease, with significant implications for patient outcomes and quality of life. Faculty explore core topics: the phenotypic spectrum of HE; how infections, sarcopenia, and gut microbiome dynamics drive recurrence; and emerging pharmacological strategies beyond traditional therapies for HE.
Speakers
-
Postgraduate Institute of Medical Education & Research
Speaker
-
GIPMER, New Delhi, India
Speaker
-
Mayo Clinic
Speaker
-
UT health San Antonio
Speaker
-
Seth GS Medical College & KEM Hospital
Moderator
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Nov 9, 2027.